Shandong Weigao Group Medical Polymer Company Limited (01066) disclosed that on 5 February 2026, 102,000 H shares were repurchased on the Hong Kong Stock Exchange at prices ranging between HKD5.23 and HKD5.36 per share. The total consideration amounted to HKD543,660. This action was made under a repurchase mandate approved on 27 May 2025, which enables the company to repurchase up to 451,560,392 shares.

Following the repurchase, the outstanding issued shares (excluding treasury shares) stood at 4,481,643,924, and the number of treasury shares increased to 40,688,400, keeping the total issued share capital at 4,522,332,324. The shares repurchased are held in treasury, and a moratorium on any new share issuance or transfer of treasury shares is in effect until 8 March 2026 as stipulated under current listing rules.